Global burden of disease attributable to illicit drug use and dependence: findings from the Global Burden of Disease Study 2010

@article{Degenhardt2013GlobalBO,
  title={Global burden of disease attributable to illicit drug use and dependence: findings from the Global Burden of Disease Study 2010},
  author={Louisa Degenhardt and Harvey A. Whiteford and Alize J. Ferrari and Amanda J. Baxter and Fiona Charlson and Wayne Hall and Greg Freedman and Roy Burstein and Nicole E Johns and Rebecca E. Engell and Abraham D. Flaxman and Christopher J. L. Murray and Theo Vos},
  journal={The Lancet},
  year={2013},
  volume={382},
  pages={1564-1574}
}
BACKGROUND No systematic attempts have been made to estimate the global and regional prevalence of amphetamine, cannabis, cocaine, and opioid dependence, and quantify their burden. [...] Key Method GBD 2010 calculated new disability weights by use of representative community surveys and an internet-based survey.Expand
The global epidemiology and burden of psychostimulant dependence: findings from the Global Burden of Disease Study 2010.
TLDR
Dependence upon psychostimulant dependent people is a substantial contributor to global disease burden; the contribution of cocaine and amphetamines to this burden varies dramatically by geographic region. Expand
Global burden of disease attributable to mental and substance use disorders: findings from the Global Burden of Disease Study 2010
TLDR
The findings show the striking and growing challenge that these disorders pose for health systems in developed and developing regions. Expand
The Global Burden of Disease projects: what have we learned about illicit drug use and dependence and their contribution to the global burden of disease?
TLDR
There is still much work to be done to generate defensible estimates of the magnitude of risk, particularly for impactful and prevalent outcomes, such as injuries, violence and mental health complications. Expand
The Global Burden of Mental, Neurological and Substance Use Disorders: An Analysis from the Global Burden of Disease Study 2010
TLDR
Mental, neurological and substance use disorders contribute to a significant proportion of disease burden and health systems can respond by implementing established, cost effective interventions, or by supporting the research necessary to develop better prevention and treatment options. Expand
The Burden Attributable to Mental and Substance Use Disorders as Risk Factors for Suicide: Findings from the Global Burden of Disease Study 2010
TLDR
Capturing the suicide burden attributable to mental and substance use disorders allows for more accurate estimates of burden and more consideration needs to be given to interventions targeted to populations with, or at risk for, mental and substances use disorders. Expand
Alcohol use and burden for 195 countries and territories, 1990–2016: a systematic analysis for the Global Burden of Disease Study 2016
TLDR
It is found that the risk of all-cause mortality, and of cancers specifically, rises with increasing levels of consumption, and the level of consumption that minimises health loss is zero. Expand
The epidemiology of drug use disorders cross-nationally: Findings from the WHO's World Mental Health Surveys.
TLDR
Substantial cross-national differences in DUD prevalence were found, reflecting myriad social, environmental, legal and other influences, Nonetheless, patterns of course and correlates of DUDs were strikingly consistent. Expand
Illicit Drugs: Patterns of Use, Dependence, and Contribution to Disease Burden in Developed Countries
TLDR
Evidence on the health risks related to cannabis and mortality associated with problem drug use and injecting drug use, and risk factors for illicit drug use in developed countries of Europe, North America, and Australasia are reviewed. Expand
Excess mortality from mental, neurological and substance use disorders in the Global Burden of Disease Study 2010
TLDR
Numbers of excess deaths and attributable deaths clearly demonstrate the high degree of mortality associated with these disorders and the life expectancy gap between persons with MNSDs and the general population is high and should be a focus for health systems reform. Expand
The global burden of mental and substance use disorders: changes in estimating burden between GBD1990 and GBD2010
TLDR
The conceptual and methodological changes to GBD burden calculations in the GBD 2010 study are reviewed, compared with previous studies, and the possible implications of these changes with respect to burden estimates for mental and substance use disorders are discussed. Expand
...
1
2
3
4
5
...

References

SHOWING 1-10 OF 60 REFERENCES
Extent of illicit drug use and dependence, and their contribution to the global burden of disease
TLDR
The regional and global distribution of use and estimated health burden from illicit drugs is outlined, and the health-related harms of cannabis use differ from those of amphetamine, cocaine, and opioid use, in that cannabis contributes little to mortality. Expand
Disability-adjusted life years (DALYs) for 291 diseases and injuries in 21 regions, 1990–2010: a systematic analysis for the Global Burden of Disease Study 2010
TLDR
The results for 1990 and 2010 supersede all previously published Global Burden of Disease results and highlight the importance of understanding local burden of disease and setting goals and targets for the post-2015 agenda taking such patterns into account. Expand
Illicit drug use.
TLDR
In cohort studies of treated drug users the problematic use of illicit drugs has been associated with an increased overall rate of mortality, and with an elevated rate of a number of individual causes of death, four of which were estimated here: AIDS, overdose, suicide and trauma. Expand
Years lived with disability (YLDs) for 1160 sequelae of 289 diseases and injuries 1990–2010: a systematic analysis for the Global Burden of Disease Study 2010
TLDR
Prevalence and severity of health loss were weakly correlated and age-specific prevalence of YLDs increased with age in all regions and has decreased slightly from 1990 to 2010, but population growth and ageing have increased YLD numbers and crude rates over the past two decades. Expand
Global and regional burden of disease and risk factors, 2001: systematic analysis of population health data
TLDR
Despite uncertainties about mortality and burden of disease estimates, the findings suggest that substantial gains in health have been achieved in most populations, countered by the HIV/AIDS epidemic in Sub-Saharan Africa and setbacks in adult mortality in countries of the former Soviet Union. Expand
What data are available on the extent of illicit drug use and dependence globally? Results of four systematic reviews.
TLDR
Qualitative evidence of illicit drug use and dependence was found for most countries, which hold over 98% of the world's population aged 15-64 years, but dependence estimates are lacking even in high income countries that have required resources. Expand
Common values in assessing health outcomes from disease and injury: disability weights measurement study for the Global Burden of Disease Study 2010
TLDR
This study represents the most extensive empirical effort as yet to measure disability weights and reports strong evidence of highly consistent results. Expand
A comparative risk assessment of burden of disease and injury attributable to 67 risk factors and risk factor clusters in 21 regions, 1990–2010: a systematic analysis for the Global Burden of Disease Study 2010
TLDR
This work estimated deaths and disability-adjusted life years (DALYs) attributable to the independent effects of 67 risk factors and clusters of risk factors for 21 regions in 1990 and 2010 and calculated the burden attributable to each risk factor exposure compared with the theoretical-minimum-risk exposure. Expand
A Systematic Review of the Prevalence of Schizophrenia
TLDR
The aims of this review are to systematically identify and collate studies describing the prevalence of schizophrenia, to summarize the findings of these studies, and to explore selected factors that may influence prevalence estimates. Expand
Mortality among regular or dependent users of heroin and other opioids: a systematic review and meta-analysis of cohort studies.
TLDR
Mortality among opioid-dependent users varies across countries and populations; treatment is clearly protective against mortality even in non-randomized observational studies; study characteristics predict mortality levels. Expand
...
1
2
3
4
5
...